HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H H Zhu Selected Research

Mucins

8/2013Complementary laboratory indices for predicting the disease status of patients with hepatitis B virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H H Zhu Research Topics

Disease

6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2019 - 03/2016
4Leukemia
01/2018 - 06/2016
3Neoplasm Metastasis (Metastasis)
05/2022 - 03/2016
2Hepatic Echinococcosis
08/2021 - 10/2019
2Hepatocellular Carcinoma (Hepatoma)
04/2020 - 06/2017
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2018 - 06/2016
2Prostatic Neoplasms (Prostate Cancer)
11/2017 - 03/2016
1Hypothyroidism
07/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022
1Fibrosis (Cirrhosis)
08/2021
1Ascites
04/2020
1Lymphatic Metastasis
04/2020
1Infections
01/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2018
1Neoplasms (Cancer)
11/2017
1Hypercholesterolemia
04/2014
1Carotid Artery Diseases
04/2014
1Chronic Hepatitis B
08/2013
1Massive Hepatic Necrosis
08/2013
1Hepatitis B
08/2013
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2008

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
08/2021 - 03/2016
2Cytarabine (Cytosar-U)FDA LinkGeneric
09/2018 - 01/2018
1PlaxIBA
07/2023
1Biomarkers (Surrogate Marker)IBA
05/2022
1B7-H1 AntigenIBA
05/2022
1Immune Checkpoint InhibitorsIBA
05/2022
1Bone Morphogenetic Protein 7IBA
08/2021
1Contrast MediaIBA
04/2020
1GelatinIBA
04/2020
1CellophaneIBA
01/2020
1AclarubicinIBA
09/2018
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2018
1DecitabineFDA Link
09/2018
1Daunorubicin (Cerubidine)FDA LinkGeneric
08/2018
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2018
1Antisense RNA (Anti-Sense RNA)IBA
11/2017
1AndrogensIBA
11/2017
1Messenger RNA (mRNA)IBA
10/2017
1Polypyrimidine Tract-Binding ProteinIBA
06/2017
1Monoclonal AntibodiesIBA
06/2017
1MicroRNAs (MicroRNA)IBA
06/2017
13,4- dihydro- alpha,alpha- dimethyl- beta- ethyl- 6- methoxy- 2-naphthalenepropionic acidIBA
06/2017
1Sorafenib (BAY 43-9006)FDA Link
12/2016
1C-Reactive ProteinIBA
04/2014
1oxidized low density lipoproteinIBA
04/2014
1Ezetimibe (Zetia)FDA Link
04/2014
1Atorvastatin (Lipitor)FDA Link
04/2014
1LipidsIBA
04/2014
1MucinsIBA
08/2013
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2013
1BilirubinIBA
08/2013
1Alanine Transaminase (SGPT)IBA
08/2013
1Chemokine CXCL2IBA
08/2013
1Imatinib Mesylate (Gleevec)FDA Link
08/2008

Therapy/Procedure

4Induction Chemotherapy
08/2018 - 03/2016
3Drug Therapy (Chemotherapy)
10/2019 - 07/2017
2Therapeutics
05/2019 - 11/2017
1Immunotherapy
05/2022
1Liver Transplantation
10/2019
1Palliative Care (Palliative Therapy)
10/2019
1CAG protocol
09/2018
1Hematopoietic Stem Cell Transplantation
01/2018
1Castration
11/2017
1Maintenance Chemotherapy
06/2016
1Aftercare (After-Treatment)
04/2014